Experts speak on tackling COVID-19

Testing strategies for the virus

Dr. Saranya Narayan, Senior microbiologist  

The year 2020 has started on a very challenging note for all of us. The world woke up to a new infection, COVID-19 caused by the SARS-CoV-2 virus. The virus was so named as it is almost similar to the SARS virus and like it, is an RNA virus belonging to the family of Corona viruses. The virus though milder than the SARS virus is easier to transmit.

The Indian Council of Medical Research (ICMR) and the State health authorities have issued notifications and guidelines for testing strategies that every testing laboratory and treating hospital need to abide by.

Who can get tested:

ICMR modified testing strategy issued on 9th April.

Tests can be done for:

All symptomatic individuals who have undertaken international travel from the 6th of March

All symptomatic contacts of laboratory confirmed cases.

All symptomatic healthcare workers.

All hospitalised patients with Severe Acute Respiratory Illness (fever and cough and/or shortness of breath)

Asymptomatic direct and high-risk contacts of a confirmed case should be tested once between day 5 and day 14 of coming in his/her contact.

In hotspots/clusters or large gatherings/evacuees centres, anyone with Influenza like illness (ILI) ie fever, cough, sore throat and runny nose

a) Within 7 days of starting symptoms need an rRT-PCR (Real time Reverse Transcriptase - Polymerase Chain Reaction) test

b) After seven days - need an Antibody test and if this negative, an rRT-PCR test to confirm status.

How does the process work?

Any person who fits into these categories, needs to have a prescription from a medical doctor, signed by the doctor, with the doctor’s registration number and contact details (telephone and email ID). These are mandatory.

In addition, the patient must carry a copy of his/her Aadhar card when they come in for testing.

Once the patient arrives for testing, the test requisition form prepared by ICMR, needs to be filled.

The ambulant patient is then escorted to a dedicated area meant for collection of the Nasopharyngeal or Oropharyngeal swab samples. The swabs are collected by trained technologists who are protected with full Personal Protection Equipment (PPE). This process takes about 10 minutes and the entire stay in the lab takes about 20 minutes.

The collected swabs are immediately placed in bottles containing Viral Transport Medium, securely closed and labelled. They are packed in multiple layers and then transported to the lab at the earliest, at a temperature of 2-8 degrees C for further processing.

In very ill, hospitalised patients, other samples such as endo-tracheal aspirate or Broncho-alveolar lavage can be collected.

The test that can detect COVID-19 infections at the earliest, is the rRT-PCR. The SARS-CoV-2 virus being an RNA virus, initially it is extracted from the sample. It is then converted into complementary DNA (cDNA) using the enzyme reverse transcriptase (hence the name). This cDNA is then amplified using the PCR. By this amplification, even minuscule quantities of RNA in the original sample can be identified and a sample can be classified as either positive or negative.

On an average, a batch of about 50-60 samples takes 8-10 hours from the start of processing to completion. Reports are usually ready the following day as the tests are run in batches and in case a report needs to be confirmed it will need an additional day.

Rapid antibody screening tests will also be available soon, but need to be used judiciously and interpreted with caution. They are ideal for assessing the prevalence of infection in a population at a later date.

Our code of editorial values

This article is closed for comments.
Please Email the Editor

Printable version | Jun 15, 2021 6:50:29 AM |

In This Series
Dr. Rahul Yadav on COVID-19 in neonates and infants
Non-COVID-19 emergencies in pandemic times
The role of palliative care
Lessons to follow after lockdown
Coronavirus | Does SARS-CoV-2 affect the liver?
Judiciously managing brain tumour patients
Don’t ignore abdominal symptoms
It’s important to protect skin
Private sector and patient safety
COVID-19: The tests reveal all
Will Vitamin C be of any help?
COVID-19 and the nervous system
Coronavirus and diabetes | Can DPP-4 inhibitors play a role?
Masks are mandatory for all now
Stroke is an exception, rush to hospital
COVID-19 enhances reliance on telemedicine
‘How I fought COVID-19 and won!’
Coronavirus | What is convalescent plasma therapy?
Palliative care is the answer
You are reading
Testing strategies for the virus
COVID-19: Breathing hard
Some tips to avoid diabetic amputations during lockdown
The virus versus women
Retaining the humanitarian approach in times of COVID-19
Do not ignore non-COVID-19 medical emergencies
In search of Vitamin D this summer of lockdown
Be alert, not anxious
Postponing elective surgeries can save lives
Sensitising parents of children with special needs
Aches and pains and a spot of exercise during COVID-19
Coronavirus | Managing pregnancy and childbirth
Coronavirus | Step up checking virus in patients, says virologist Jacob John
Boosting immunity is need of the hour
A look into key aspects of virus pandemic
COVID-19’s gut connection
Fighting a virus with dedicated health cadre
COVID-19 | Will it be polite with children?
Lessons from a pandemic: It’s OK to be smart
Does COVID-19 have a link with the eyes?
Sleepless during a pandemic: Insomnia going viral
Because the mind matters
Coronavirus | Are diabetics more prone to COVID-19?
What does COVID-19 mean for kidneys?
Next Story